BARBARA CARTABUKE-MULE: Open Payments
NPI 1962492389 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,965 in 119 payments from 25 companies in 2025. Trend: 2023 $2,684 · 2024 $2,866 · 2025 $2,965
Food & beverage: $2,965
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 18 | $276 |
| Lilly USA, LLC | 11 | $263 |
| Novartis Pharmaceuticals Corporation | 10 | $220 |
| IBSA Pharma Inc. | 1 | $217 |
| Xeris Pharmaceuticals, Inc. | 9 | $208 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $176 |
| SANOFI-AVENTIS U.S. LLC | 7 | $168 |
| RECORDATI_RARE_DISEASES_INC. | 6 | $166 |
| Abbott Laboratories | 8 | $137 |
| Alexion Pharmaceuticals, Inc. | 4 | $117 |
Products named: JARDIANCE, Kerendia, LEQVIO, Tirosint, TZIELD, ISTURISA, GVOKE HYPOPEN, MOUNJARO.
Industry payments across NY — which companies pay providers there.
